Dominant lethal effects of nocodazole in germ cells of male mice

S M Attia1, S F Ahmad2, R M Okash3

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia; Department of Pharmacology and Toxicology, College of Pharmacy, Al-Azhar University, Cairo, Egypt.

Insights

The anticancer drug nocodazole induces dominant lethal mutations in male germ cells, affecting sperm count and motility. This highlights potential reproductive risks for cancer patients and medical personnel undergoing nocodazole chemotherapy.

Area of Science:

  • Toxicology
  • Reproductive Toxicology
  • Genetics

Background:

  • Nocodazole is an anticancer drug used in chemotherapy.
  • Evaluating the mutagenic potential of chemotherapeutic agents is crucial for patient safety.

Purpose of the Study:

  • To investigate the ability of nocodazole to induce dominant lethal mutations in male germ cells.
  • To assess the effects of nocodazole on sperm parameters and reproductive outcomes.

Main Methods:

  • In vivo dominant lethal test in mice.
  • Mice were treated with varying doses of nocodazole (15, 30, 60 mg/kg).
  • Sperm count, motility, and abnormality were analyzed; males were mated weekly for 6 weeks.

Main Results:

  • Nocodazole induced dominant lethal mutations, particularly in early spermatids and mature spermatozoa at higher doses.
  • Significant decreases in sperm count and motility were observed with 30 and 60 mg/kg doses.
  • Increased percentage of abnormal sperm was noted at middle and highest doses.

Conclusions:

  • Nocodazole is confirmed as a germ cell mutagen.
  • Nocodazole significantly impacts sperm maturation and development.
  • Potential reproductive risks exist for individuals exposed to nocodazole.